|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
799320048 |
| 003 |
DE-627 |
| 005 |
20230426093527.0 |
| 007 |
tu |
| 008 |
141030s2014 gw ||||| 00| ||ger c |
| 035 |
|
|
|a (DE-627)799320048
|
| 035 |
|
|
|a (DE-599)GBV799320048
|
| 035 |
|
|
|a (OCoLC)897126422
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a ger
|
| 044 |
|
|
|c XA-DE
|c XD-US
|
| 082 |
0 |
4 |
|a 610
|q DNB
|
| 084 |
|
|
|a YG 2603
|q BSZ
|2 rvk
|0 (DE-625)rvk/153484:12909
|
| 084 |
|
|
|a 44.38
|2 bkl
|
| 084 |
|
|
|a 44.90
|2 bkl
|
| 245 |
1 |
0 |
|a Alemtuzumab
|b Behandlung der Multiplen Sklerose
|c [Hrsg.: Thomas Postert]
|
| 264 |
|
1 |
|a Stuttgart [u.a.]
|b Thieme
|c 2014
|
| 300 |
|
|
|a 15 S.
|b Ill., graph. Darst.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a Thieme case report
|v 6.2014,11
|
| 700 |
1 |
|
|a Postert, Thomas
|0 (DE-588)1037491742
|0 (DE-627)755833414
|0 (DE-576)391527894
|4 oth
|
| 830 |
|
0 |
|a Thieme case report
|v 6.2014,11
|9 2014000611
|w (DE-627)615767559
|w (DE-576)316278165
|w (DE-600)2531425-7
|x 1611-7875
|7 ns
|
| 912 |
|
|
|a GBV_ILN_74
|
| 912 |
|
|
|a ISIL_DE-354
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 936 |
r |
v |
|a YG 2603
|b Kompendien, Repetitorien, Leitfäden, Kurzdarstellungen, programmierter Unterricht
|k Medizin
|k Neurologie
|k Allgemeine Neurologie
|k Allgemeine Therapie
|k Medikamentöse Therapie
|k A. Formalschlüssel
|k Kompendien, Repetitorien, Leitfäden, Kurzdarstellungen, programmierter Unterricht
|0 (DE-627)1277423083
|0 (DE-625)rvk/153484:12909
|0 (DE-576)207423083
|
| 936 |
b |
k |
|a 44.38
|j Pharmakologie
|0 (DE-627)106409743
|
| 936 |
b |
k |
|a 44.90
|j Neurologie
|0 (DE-627)106409980
|
| 951 |
|
|
|a BO
|
| 980 |
|
|
|2 74
|1 01
|x 0354
|b 1507233000
|c 00
|f Magazin
|d Z 5104-6,11
|e u
|j --%%--
|y zb
|z 30-10-14
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 00
|a Antibodies, Monoclonal, Humanized
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 01
|a Antineoplastic Agents-therapeutic use
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 02
|a Multiple Sclerosis-drug therapy
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 50
|a Case Reports
|
| 984 |
|
|
|2 74
|1 01
|x 0354
|a 354$13142704
|
| 985 |
|
|
|2 74
|1 01
|x 0354
|a Z 5104-6,11
|
